Related Experiment Video
Updated: Jul 15, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Long-Term Cumulative High-Sensitivity C-Reactive Protein and Mortality Among Patients With Acute Heart Failure
Lihua Zhang1, Guangda He1, Xiqian Huo1
1National Clinical Research Center for Cardiovascular Diseases, NHC Key Laboratory of Clinical Research for Cardiovascular Medications, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of China.
Insights
Elevated long-term cumulative high-sensitivity C-reactive protein (hsCRP) levels indicate a worse prognosis for patients hospitalized with heart failure. Repeated hsCRP measurements can help identify high-risk individuals for mortality.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation
Background:
- Elevated high-sensitivity C-reactive protein (hsCRP) is linked to poorer outcomes in hospitalized heart failure patients.
- The prognostic significance of long-term cumulative hsCRP levels in heart failure is not well understood.
Purpose of the Study:
- To investigate the association between long-term cumulative hsCRP levels and mortality in patients hospitalized for heart failure.
- To determine if repeated hsCRP measurements improve risk stratification for heart failure patients.
Main Methods:
- Consecutive enrollment of 1281 heart failure patients, with hsCRP measurements at admission, 1 month, and 12 months post-discharge.
- Evaluation of long-term cumulative hsCRP using quartiles and frequency of elevated levels (0-3 times) over the follow-up period.
- Multivariable Cox regression models were employed to analyze the relationship between cumulative hsCRP and all-cause mortality over a median of 4.8 years.
Main Results:
- Higher quartiles of cumulative hsCRP levels were significantly associated with increased mortality risk (HR for Q4 vs. Q1: 2.38).
- Patients with more frequent elevated hsCRP levels (2 or 3 times) demonstrated substantially higher mortality risk compared to those with 0 times (HR for 3-times: 2.80).
- A dose-response relationship was observed between increasing cumulative hsCRP burden and mortality.
Conclusions:
- Increasing long-term cumulative hsCRP levels are a significant predictor of worse outcomes in patients hospitalized for acute heart failure.
- Serial hsCRP measurements provide valuable prognostic information, aiding clinicians in identifying patients at high risk of death.
Abstract:
Background Elevated hsCRP (high-sensitivity C-reactive protein) level is associated with worse prognosis among patients hospitalized for heart failure. However, the prognostic value of the long-term cumulative hsCRP remains unknown. Methods and Results We consecutively enrolled patients hospitalized for heart failure and collected their hsCRP data at admission and 1 and 12 months after discharge. Long-term cumulative hsCRP was evaluated using 2 approaches, cumulative hsCRP level quartiles and cumulative times of high hsCRP levels. Patients were classified into 4 groups by cumulative hsCRP level quartiles and cumulative times of high hsCRP levels (0- to 3-times: number of times that hsCRP levels were higher than cutoff values at admission or 1 or 12 months), respectively. Multivariable Cox models were used to assess the association of mortality with cumulative hsCRP. A total of 1281 patients were included; the median age was 64 (interquartile range, 54-73) years, and 35.4% were women. Over a 4.8-year (interquartile range, 4.2-5.1) follow-up, 374 (29.2%) patients died. Elevated long-term cumulative hsCRP level was related to higher mortality. Specifically, taking the quartile 1 as the reference, the hazard ratios (HRs) were 1.29 (95% CI, 0.92-1.81) for quartile 2, 1.62 (95% CI, 1.16-2.25) for quartile 3, and 2.38 (95% CI, 1.75-3.23) for quartile 4. Similarly, compared with the patients with 0-times (hsCRP level lower than the cutoff values in all 3 time points) of high hsCRP level, the HRs were 1.36 for 1-time (hsCRP level higher than the cutoff value in one of the 3 time points) (95% CI, 0.92-2.01), 1.95 for 2-times (hsCRP levels higher than the cutoff values in 2 of the 3 time points) (95% CI, 1.34-2.82), and 2.80 for 3-times (hsCRP levels higher than the cutoff values in the 3 time points) (95% CI, 1.97-4.00). Conclusions Increasing long-term cumulative hsCRP level was associated with worse outcomes in patients hospitalized for acute heart failure. Repeated hsCRP measurements could assist physicians in identifying patients with a high risk of death. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02878811.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease IV: Nursing Management